Hepatitis C Flashcards
Hepatitis C - Diagnosis
ELISA: detect HCV antibodies. Detectable in acute disease between 6-12 weeks after infection.
If ELISA antibody test is positive: PCR; detects presence of viral RNA (viral load) in serum –> determine whether active disease exists.
Chronic infection:
Elevated transaminase levels, positive ELISA, detectable viral RNA for at least 6 months. Liver biopsy to evaluate extent of liver damage and guide treatment; staging.
Genotyping: important for therapy
Liver damage:
Magnetic resonance elastography: check liver stiffness
Biopsy
CT/MRI
Test for HBV and HIV
Lab findings: Increased AST and ALT Increased bilirubin and urobilinogen Lymphocytosis Prolonged PT Increased gamma globulin fraction Increased IgG and IgM
Acute Hep. C - Treatment
Spontaneous resolution may occur, observe for 6 months before starting therapy
Sofosbuvir - 400 mg PO + Ledipasvir - 90 mg PO once daily for 6 weeks
Sofosbuvir - MoA
RNA polymerase inhibitor
Sofosbuvir and Ledipasvir - Adverse effects
fatigue, headache, nausea, weakness
Sofosbuvir and Ledipasvir - Interactions
Barbiturates: decreases concentration via P-glycoprotein
Sofosbuvir and Ledipasvir - Contraindications
Pregnancy
Renal failure
Chronic Hep C - Treatment
Sofosbuvir - 400 mg PO + Velpatasvir (100 mg) for 12 weeks
Velpatasavir - MoA
NS5A inhibitor
Velpatasavir - Adverse effects
Headache, weakness, nausea
Velpatasavir - Interaction
Barbiturates induces metabolism via CYP3a4
Velpatasavir - Contraindication
Drugs that induces cyp3a4 such as barbiturates.